Reiberger, Thomas <br/><br/>
Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signalling.  [electronic resource] 

 -  Liver international : official journal of the International Association for the Study of the Liver  Apr 2013 
 - 561-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1478-3231 
<br/><br/><label>Standard No.: </label>10.1111/liv.12101  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adrenergic beta-Antagonists--administration & dosage<br/>Animals<br/>Benzopyrans--administration & dosage<br/>Blood Flow Velocity--drug effects<br/>Collateral Circulation--drug effects<br/>Common Bile Duct--surgery<br/>Dose-Response Relationship, Drug<br/>Ethanolamines--administration & dosage<br/>Glutathione--metabolism<br/>Heart Rate--drug effects<br/>Hypertension, Portal--etiology<br/>Ligation<br/>Liver--blood supply<br/>Liver Circulation--drug effects<br/>Liver Cirrhosis, Experimental--complications<br/>Male<br/>Mesenteric Artery, Superior--drug effects<br/>Nebivolol<br/>Nitric Oxide--metabolism<br/>Oxidation-Reduction<br/>Portal Pressure--drug effects<br/>Rats<br/>Rats, Sprague-Dawley<br/>Signal Transduction--drug effects<br/>Splanchnic Circulation--drug effects<br/>Up-Regulation